Validation of image-derived input function using a long axial field of view PET/CT scanner for two different tracers

Study population

Between November 2022 and July 2023, 8 consecutive patients with [18F]FDG injection from a prospective study including patients with various diseases (TBPETCT001 study) and 10 consecutive patients with post COVID syndrome with [18F]DPA-714 injection from the VeCosCO study [21] scanned on the Siemens Biograph Vision Quadra at the Amsterdam UMC, location VUmc (the Netherlands) were included. Informed consent was obtained for all patients. These studies were approved by the Medical Ethics Review Committee of the Amsterdam UMC. The patients with [18F]DPA-714 injection were all high affinity binders based on TSPO genotype analysis.

PET/CT data

Patients received 241 ± 61 MBq of [18F]FDG and 222 ± 27 MBq of [18F]DPA-714. All PET scans were performed after a low dose CT scan acquired without contrast agents. Acquisition of list-mode PET data started immediately after injection of the tracer. For [18F]FDG PET, the 70-min dynamic imaging data were binned into 20 frames (1 × 15 s, 3 × 5 s, 3 × 10 s, 4 × 60 s, 2 × 150 s, 2 × 300 s, 5 × 600 s). For [18F]DPA-714 PET, the 60-min dynamic imaging data were binned into 19 frames (1 × 15 s, 3 × 5 s, 3 × 10 s, 4 × 60 s, 2 × 150 s, 2 × 300 s, 4 × 600 s). For each scan, 9 different PET reconstructions were done using a dedicated offline reconstruction workstation (E7, Siemens Healthineers, Knoxville, TN, USA). All of the reconstructions shared the following settings: PSF + TOF OSEM algorithm, 5 subsets, decay correction, scatter correction and CT-based attenuation correction. The voxel size in the z direction was CT-matched (2 mm) or not CT-matched (1.65 mm). For each scan, this value was identical between reconstructions. For the scatter correction, relative scaling of the scatter correction is the default recommended option, but the use of absolute scatter scaling was explored as well. The other settings for the 9 reconstructions are detailed in Table 1.

Table 1 Reconstruction settingsIDIF validation using calibration assessment with manual blood samples

For all patients, IDIFs were taken from a 2 × 2 (with matrix 220 × 220) or 4 × 4 (with matrix 440 × 440) voxels region placed centrally on five adjacent slices in the DA and LV on the updated European Association of Nuclear Medicine Research Ltd. standard reconstruction (EARL2) [22] used as reference and in the AA on all of the reconstructions (11 IDIFs in total: 9 derived from AA with different reconstruction settings, 1 IDIF from DA with EARL2 reconstruction and 1 IDIF from LV with EARL 2 reconstruction) using the ACCURATE software tool (developed in IDLversion 8.4 (Harris Geospatial Solutions, Bloomfield, USA)) [23]. For patients with [18F]FDG injection, 3 manual venous samples were used for calibration of the 11 different IDIFs (35, 45 and 60 min post-injection because the arterio-venous [18F]FDG concentration equilibrium is reached around 40 min post-injection [24]). For patients with [18F]DPA-714 injection, 4 manual arterial samples (at 20, 40, 60 and 75 min post-injection) were used for calibration of the 11 different IDIFs and for the input function obtained from an arterial continuous sampler (Comecer, Joure, the Netherlands). The calibration factor (CF) was the mean of the ratio between the whole blood activity from the manual samples and the whole blood activity from the IDIF (or the input function from the arterial continuous sampler for [18F]DPA-714) at the corresponding time points [12]. The CF was used for IDIFs accuracy and precision assessment.

Uptake ratio between organs and aorta

In order to quantify the uptake for each tracer in the main organs close to the aorta which may affect the accuracy and the precision of IDIF, a VOI was manually drawn in the liver, lung, myocardium and spleen on the EARL2 reconstruction. The standardized uptake value normalized to body weight (SUVbw) for each organs VOI and AA was based on 50–60 min post-injection time interval.

Illustration of the impact of different calibrated-IDIFs using kinetic modellingBlood processing

For [18F]FDG, calibrated IDIFs were corrected for plasma to whole-blood ratios to obtain plasma input functions. The calibrated whole-blood curve was multiplied with the function obtained from interpolation between plasma-to-whole blood ratio values from the manual samples to generate the corresponding whole-plasma curve.

For [18F]DPA-714, calibrated IDIFs and input function from continuous sampler were corrected for plasma to whole-blood ratios and metabolites to obtain metabolite corrected plasma input functions. The method for plasma/whole blood correction was the same method as described above for [18F]FDG. Additionally, for metabolite corrections, parent fractions measured in the manual plasma samples were fitted to a Hill function [25]. Each individual whole-plasma curve was then multiplied by the corresponding fitted Hill function.

Kinetic modelling

For [18F]FDG, Patlak linearization [26] (using t* = 30 min) was performed to estimate the net tracer flux Ki (mL·cm− 3·min− 1) using the 11 different calibrated IDIFs and using a same target tissue time-activity-curve (TAC) from a VOI manually drawn using the EARL2 reconstruction on the striatum. Four patients did not have any high tumor uptake so the striatum was chosen as target region because it is a region with high level uptake similar to that seen in cancers. The EARL2_AA IDIF was used as reference because arterial continuous sampler was not available for [18F]FDG. Moreover, EARL2 is the standard reconstruction for whole-body and because a previous study concluded that AA is the structure of choice for defining IDIF for [18F]FDG [8]. Therefore, the Ki extracted with the 10 others calibrated IDIFs were compared to the Ki extracted with the calibrated EARL2_AA IDIF.

For [18F]DPA-714, Logan linearization [27] (using t* = 30 min) was performed to estimate the distribution volume (VT) (mL·cm− 3) using the 11 different calibrated IDIFs and using a same target tissue time-activity-curve from a VOI manually drawn using the EARL2 reconstruction on the cerebral frontal region. The brain was chosen because post COVID syndrome might be associated with cerebral neuroinflammation on [18F]DPA-714 PET [28]. The VT extracted with the 11 calibrated IDIFs were compared to the VT extracted with the calibrated input function obtained from an arterial continuous sampler used as reference. The kinetic modelling was performed using in-house developed software.

留言 (0)

沒有登入
gif